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Differential monocular vs. 
binocular pupil responses from 
melanopsin-based photoreception 
in patients with anterior ischemic 
optic neuropathy
Chrysanthi Tsika1,2, Sylvain V. Crippa1 & Aki Kawasaki1
We examined the effect of anterior ischemic optic neuropathy (AION) on the activity of intrinsically 
photosensitive retinal ganglion cells (ipRGCs) using the pupil as proxy. Eighteen patients with AION 
(10 unilateral, 8 bilateral) and 29 age-matched control subjects underwent chromatic pupillometry. 
Red and blue light stimuli increasing in 0.5 log steps were presented to each eye independently 
under conditions of dark and light adaptation. The recorded pupil contraction was plotted against 
stimulus intensity to generate scotopic and photopic response curves for assessment of synaptically-
mediated ipRGC activity. Bright blue light stimuli presented monocularly and binocularly were used 
for melanopsin activation. The post-stimulus pupil size (PSPS) at the 6th second following stimulus 
offset was the marker of intrinsic ipRGC activity. Finally, questionnaires were administered to assess 
the influence of ipRGCs on sleep. The pupil response and PSPS to all monocularly-presented light 
stimuli were impaired in AION eyes, indicating ipRGC dysfunction. To binocular light stimulation, the 
PSPS of AION patients was similar to that of controls. There was no difference in the sleep habits of 
the two groups. Thus after ischemic injury to one or both optic nerves, the summated intrinsic ipRGC 
activity is preserved when both eyes receive adequate light exposure.
The intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanop-
sin which confers the capacity of intrinsic phototransduction1,2. The spectral sensitivity of melanopsin 
is broad with a peak sensitivity to short wavelength light in the blue portion of the visual spectrum. 
Compared to rod and cone photoreceptors, the melanopsin photoresponse is slow and insensitive2–4. Its 
unique features are, however, the ability to sustain a steady-state depolarization of ipRGCs during con-
tinuous illumination and to maintain ipRGC firing for some time after termination of the stimulus light2.
The ipRGCs mediate non-visual, light-dependent functions such as entrainment of the circadian clock 
and pupillary responses to light changes3,5. In macaque monkeys whose eyes have been pharmacologi-
cally treated to block hyperpolarization of rods and cones, the intrinsic melanopsin photoresponse can be 
isolated and it is capable of driving a strong pupillary contraction6. In eyes with intact rods and cones, the 
overlap of spectral and luminance sensitivities between rod, cone and melanopsin photosystems precludes 
isolation of the melanopsin photoresponse. In normal eyes, the light signal relayed by ipRGCs is an inte-
gration of their intrinsic, melanopsin mechanism and extrinsic, synaptically-transmitted influences from 
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rods and cones4,7,8. The rapid kinetics of rod and cone activation are primarily reflected in the immediate 
pupil response to light onset and offset whereas the slow kinetics of the melanopsin photoresponse are 
better discerned in the post-stimulus pupillary behavior. Specifically, a protracted contraction of the 
pupil after termination of the light stimulus appears to be mediated primarily by melanopsin6,9–12.
The ipRGCs have a different morphology and retinal distribution compared to conventional 
vision-mediating retinal ganglion cells4,5. In addition, there is a growing body of evidence that ipRGCs 
display greater resistance to certain models of ganglion cell injury and death13–19. This robustness of 
ipRGCs is the basis for the visual-pupillary dissociation that is observed in patients with isolated hered-
itary mitochondrial optic neuropathy. These patients have significant visual loss and optic atrophy in 
both eyes and yet demonstrate normal pupil responses to light and have normally entrained sleep-wake 
cycles19–21.
On the other hand, glaucomatous optic neuropathy does not appear to spare ipRGCs and 
melanopsin-mediated functions. Two studies have shown that patients with advanced glaucoma have 
diminished pupil contraction amplitudes to light as well as a reduced post-illumination pupil con-
traction22,23. Glaucoma patients also show a reduction in the light-induced suppression of nocturnal 
melatonin secretion and have disturbances in sleep quality. Taken together, these findings implicate 
involvement of ipRGCs in glaucomatous optic neuropathy24,25.
Anterior ischemic optic neuropathy (AION) represents an optic nerve disorder in which the primary 
insult is insufficient perfusion to the optic nerve head. This leads to axoplasmic stasis and swelling, 
followed by axonal dropout and loss of retinal ganglion cells26. Presumably, the ischemic damage is 
non-selective and involves both visual retinal ganglion cells and ipRGCs. Clinical examination demon-
strates loss of visual function and there may be impaired pupillary function that is detectable as a relative 
afferent pupillary defect (RAPD). The present study aimed to examine the effect of ischemic optic nerve 
damage on the functional integrity of ipRGCs through a more complete assessment of pupil responses 
to light. Specifically, we quantified the pupil response to light stimuli of varying spectral wavelength and 
intensity that were pre-selected to bias activation in favor of one photoreceptor system. The melanopsin 
photoresponse is specific to ipRGCs, and this was our primary parameter of interest. We assessed this 
intrinsic activity of ipRGCs from the post-stimulus pupil size following monocular as well as binocular 
light stimulation in patients with unilateral and bilateral AION. Finally, we surveyed the sleep habit 
of these patients via standardized questionnaires27–29 to understand how AION in one or both eyes 
might influence downstream physiologic processes such as sleep homeostasis which is strongly linked to 
melanopsin-based light signaling30.
Results
The 18 patients with AION were 8 men and 10 women (aged 26 to 69 years) and the 29 control subjects 
were 10 men and 19 women (aged 24 to 70 years). Ten patients had unilateral AION of the non-arteritic 
type and henceforth are called the “unilateral group”. The “bilateral group” was comprised of one patient 
with bilateral non-arteritic AION and 7 patients with bilateral AION associated with optic disc drusen31.
The unilateral group was 4 men and 6 women having a median age of 67 years with a range between 
50 to 69 years. The clinical characteristics of this group and a subgroup of 10 age-matched controls are 
given in Table 1. The affected eyes of the unilateral group demonstrated significantly reduced visual func-
tion (acuity, color vision and visual field) and significantly reduced thickness of the peripapillary retinal 
nerve fiber layer (RNFL). All affected eyes demonstrated an RAPD on clinical examination, though it was 
generally small (median 0.6 log-units, range 0.3 to 1.2 log-units). The RAPD was significantly correlated 
with the interocular difference in mean deviation (MD) of the visual field defect (correlation coefficient 
0.64, p = 0.046) but not with visual acuity, color vision or RNFL. The ophthalmologic status of the unaf-
fected eyes of the unilateral group was similar to age-matched control eyes.
A schematic of the light stimuli used in 4 testing protocols is shown in Fig.  1. The response curve 
and the half-maximal response (logI50) derived from pupil responses to the rod-weighted protocol 
(dark-adapted, dim blue light stimuli) and to the cone-weighted protocol (light adapted, bright red light 
stimuli) are shown in Fig. 2 for the unilateral group and age-matched controls. Compared to unaffected 
eyes and control eyes, eyes with AION showed diminished pupil contraction amplitudes and generally 
less sensitive scotopic and photopic response curves. As expected, the logI50 for the rod-weighted pro-
tocol was higher in affected eyes compared to unaffected eyes and controls eyes but the difference was 
not significant (median logI50 = − 2.17 log cd/m2 for affected eyes, − 2.53 log cd/m2 for unaffected eyes, 
− 2.58 log cd/m2 for controls, p = 0.37). For the cone-weighted protocol, there was no significant differ-
ence in the median logI50 between affected eyes, unaffected eyes and controls eyes ( p = 0.83).
As previously mentioned, the intrinsic melanopsin response to light is sluggish and for this reason, 
when an activating light is abruptly turned off, the pupil tends to stay contracted instead of re-dilating 
immediately6,11. We measured the post-stimulus pupil size (PSPS) as a marker of melanopsin activation 
to different light intensities in each eye independently. At intensities of 1.0 log cd/m2 and 1.5 log cd/m2, 
there was no difference in the median PSPS between affected eyes, unaffected eyes and age-matched con-
trol eyes (p = 0.17 and p = 0.26, respectively). This is consistent with a previous study in which these lower 
light intensities failed to elicit a measurable post-illumination pupil contraction32. At a stimulus intensity 
of 2.0 log cd/m2, there was a significant difference in the PSPS between groups (p = 0.001). The pupil 
response from eyes affected by AION demonstrated a relative inability to maintain a post-illumination 
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pupillary contraction compared to unaffected eyes and control eyes (Fig. 3). To a 2.0 log cd/m2 blue light, 
the median PSPS of affected eyes was significantly larger compared to fellow unaffected eyes (81.2 and 
68.5, respectively, p = 0.005) and larger compared to control eyes (81.2 and 62.8, respectively, p = 0.003). 
Between unaffected eyes and controls eyes, there was no significant difference in PSPS (p = 0.18).
Age (in years)
Affected 
Eye
Visual Acuity 
(unaffected eye/
affected eye) 
(decimal)
Mean defect 
(unaffected eye/
affected eye) (dB)
RAPD (log-
units)
Peripapillary RNFL 
(unaffected eye/affected 
eye (microns)
P1 67 OD 1.0/0.4 0/15.8 1.2 90/78
P2 67 OD 1.0/0.8 − 1.3/10.2 1.2 102/77
P3 66 OD 1.0/0.5 − 0.8/22.5 0.6 92/52
P4 50 OS 1.0/1.0 0.6/13.7 0.3 91/56
P5 69 OD 1.0/1.0 − 0.7/1.2 0.3 100/88
P6 68 OS 1.0/0.8 1.5/4.1 0.3 89/84
P7 66 OS 1.0/0.5 − 0.4/3.3 0.6 103/67
P8 62 OD 1.0/0.8 1.0/5.2 0.3 101/84
P9 60 OS 1.0/0.1 1.0/15.2 0.9 88/45
P10 68 OD 1.0/0.8 − 0.4/16.3 0.9 96/53
Affected eye 
of patients
Median: 67 
(range: 50–69) 0.8 (0.1–1.0) 11.95 (1.2 to 22.5) 0.6 (0.3-1.2) 72 (45–88)
Unaffected  
eye of patients –
a1.0 p = 0.002
a− 0.2 (− 1.3 to 1.5) 
p = 0.000210 0.0
a94 (88–103) p = 0.000181
Control eye of 
age-matched 
subjects 
(n = 10)
Median: 66 
(range: 47–70)
b1.0 p = 0.002
b0.0 (− 8.40 to 1.40) 
p =  0.000245 0.0
b85 (74–110) p = 0.01
Table 1. Clinical summary of 10 patients (P1-P10) with unilateral non-arteritic AION. The abbreviations 
included are the following: dB: decibel units, RAPD: relative afferent pupillary defect, RNFL: retinal nerve 
fiber layer. Statistically significant differences are depicted with small Latin letters as follows: asignificant 
difference (p < 0.05) between affected eyes and unaffected eyes of patients with unilateral non-arteritic 
AION. bsignificant difference (p < 0.05) between affected eyes of patients and matched eyes of control 
subjects.
Figure 1. Schematic diagram of the light stimuli used in the four testing protocols. The rod-weighted 
protocol was presented to a dark adapted eye. The cone and melanopsin protocols were performed under 
light adapted conditions. The flat line indicates the time of darkness before and after each light stimulus. The 
vertical bar indicates the duration and timing of the light stimuli. The color of the bar indicates the color of 
the light stimulus. The number over each colored bar is the stimulus intensity in log cd/m2.
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The bilateral AION group was 4 men and 4 women with a median age of 50 years and ranging 
between 26 and 65 years. Table 2 provides the ophthalmologic data of each eye for these 8 patients and 
summary data for 29 control eyes. The eye with the RAPD was named the worse eye and showed sig-
nificantly greater visual field loss compared to the better eye (median MD for worse eyes = 15.1dB , for 
better eyes = 6.2 dB, difference in MD = 8.9dB, p = 0.042). There was no significant difference in visual 
acuity or RNFL thickness between the worse eye and better eye (difference in acuity = 0.2, p = 0.168 and 
difference in RNFL = 6 μ m, p = 0.160).
The degree of visual dysfunction and the thinning of RNFL from AION were similar between the 
unilateral group and the bilateral group. The visual field loss of affected eyes of the unilateral group 
(median MD 10.8 dB) was intermediate between the better and worse eyes of the bilateral group but these 
differences were not significant (p = 0.12 and p = 0.197, respectively). The visual acuity of the unilateral 
group was lower (median 0.8) compared to the bilateral group whose median acuity in each eye was 
1.0; this difference was also not significant (p = 0.051). The median RNFL thickness was 72, 74 and 62 
microns (μ m) for affected eyes of the unilateral group, better eyes of the bilateral group and worse eyes 
of the bilateral group, respectively; p = 0.316.
From the logI50, the relative pupil deficit was also similar between the unilateral group and the bilat-
eral group (p = 0.91 for cone-weighted protocol, p = 0.8 for rod-weighted protocol). The pupil responses 
from the rod-weighted protocol were reduced in both eyes of patients with bilateral AION (Fig. 4). As 
with unilateral AION, the rod-weighted logI50 for both affected eyes was higher compared to control eyes 
but the difference did not quite reach significance (median logI50 for better eyes = − 2.40 log cd/m2, for 
worse eyes = − 2.31 log cd/m2 compared to − 2.60 log cd/m2 for control eyes, p = 0.10). The individual 
Figure 2. (Top) Pupil responses to blue light stimuli (rod-weighted protocol) and red light stimuli 
(cone-weighted protocol) for 10 patients with unilateral non-arteritic AION and 10 age-matched control 
subjects. An exponential curve is fitted through the median contraction amplitude obtained at each stimulus 
intensity for 3 groups of eyes: affected eyes of AION patients, unaffected eyes of AION patients and matched 
eyes of controls. (Bottom) Scatterplot of logI50 for affected eyes and unaffected eyes of 10 patients with 
unilateral AION and 10 age-matched control eyes. The horizontal bar represents the median value.
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pupil responses to photopic red lights (cone-weighted protocol) were highly variable in all groups but 
the median response curves for these 3 groups of eyes were similar. There was no difference in the 
cone-weighted logI50 between groups (p = 0.76).
There was no significant difference in the PSPS between the two eyes of the bilateral group at any 
of the blue light intensities used in the monocular melanopsin-weighted protocol (1.0 log cd/m2 stimu-
lus, p = 0.310; 1.5 log cd/m2 stimulus, p = 0.208; 2.0 log cd/m2 stimulus, p = 0.208). There was also no 
difference in the PSPS of either eye of the bilateral group as compared to affected eyes of the unilateral 
group (worse eyes, p = 0.79 and better eyes, p = 0.51).) The PSPS of the better eyes of the bilateral group 
tended to be smaller (more contracted) compared to control eyes but the difference was not significant at 
any intensity (p = 0.337, 0.507 and 0.077 for 1.0, 1.5 and 2.0 log cd/m2 stimulus intensities, respectively). 
Figure 3. Left: Pupillometric recording of the pupil response (median) to a blue light stimulus (2.0 log cd/
m2) from affected and unaffected eyes of 10 patients with unilateral non-arteritic AION and matched eyes 
from 10 age-matched control subjects. Right: Box plot of the PSPS (pupil size at the 6th second after light 
termination shown by a dotted line on the tracing) determined for the 2.0 log cd/m2 blue light stimulus for 
the same 3 groups of eyes. The center bar is the median value, the box limits represent the 25th and 75th 
percentiles and the bar limits are the 5th and 95th percentiles. P-values are given for comparison of affected 
eyes to unaffected eyes and affected eyes to control eyes.
Patient 
Age (in 
years)
Visual Acuity (decimal) 
OD/OS Mean defect (dB) OD/OS
RAPD 
(log-units)
Peripapillary RNFL 
(microns) OD/OS
P1 65 1.0/0.4 13.3/19.4 0.9 OS 56/57
P2 47 1.0/1.0 8.6/13 0.3 OS 67/63
P3 26 0.8/1.0 21.3/0.6 0.9 OD 49/100
P4 36 1.0/1.0 4/13.7 0.9 OS 105/53
P5 29 1.0/1.0 5.2/16.7 0.3 OS 71/66
P6 53 1.0/1.0 10/16 0.6 OS 57/59
P7 53 1.0/1.0 5/11.7 0.3 OS 55/53
P8 62 1.0/1.0 2.9/9.1 0.3 OS 77/81
All patients (n = 8)
Median: 
50 
(range 
26–65)
1.0(0.8–1.0)/1.0(0.4–1.0) 6.9(2.9–21.3)/13.35(0.6–19.4) 0.5 (0.3-0.9) 62(49–105)/61(53–100)
Control eye of 
healthy subjects 
(n = 29)
Median: 
46 
(range 
24–70)
1.0/1.0 1.66(− 6.9 –2.3)/1.96(− 8.4–1.4) 0.0 92(75–110)/92(74–111)
Table 2.  Clinical summary of 8 patients with bilateral AION. The abbreviations included are the following: 
dB: decibel units, RAPD: relative afferent pupillary defect, RNFL: retinal nerve fiber layer.
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There was, however, a significant difference in the post-illumination pupil response at the brightest inten-
sity when comparing the PSPS of the worse eyes of the bilateral group to control eyes (0.81 and 0.63, 
respectively, p = 0.003).
From the binocular melanopsin-weighted protocol, the median PSPS to blue light at 2.3 log cd/m2 
showed a significant group effect (p = 0.007) but this did not remain when groups were matched for 
age (Fig.  5). For the unilateral group and age-matched controls, the median PSPS was 0.61 and 0.54, 
respectively, and this difference was not significant (p = 0.20). Similarly for the bilateral group and 29 
controls having similar median age, there was no difference in median PSPS (0.58 and 0.52 respectively, 
p = 0.051). We also determined the difference in PSPS between the blue light and an equivalent red light, 
as the red light is used as a reference light stimulus for absence of melanopsin contribution. The differ-
ence value was 0.27, 0.30 and 0.32 for the unilateral group, bilateral group and controls respectively, and 
these median values were not significantly different (p = 0.07).
For sleep habits, the unilateral group scored 70 on the Horne and Östberg (HO) Morningness-Eveningness 
questionnaire, as compared to 57 for the bilateral group and 60 for 29 controls. The controls and uni-
lateral group were generally classified as morning types whereas the bilateral group was an intermediate 
type between morning and evening. From the Pittsburgh Sleep Quality Index (PSQI) questionnaire, 4 
patients (2 unilateral AION, 2 bilateral AION) and 4 controls had a global score > 5 which is the thresh-
old score indicating poor sleep quality. The median scores for unilateral, bilateral and control groups 
were 3, 4 and 4 respectively, and the differences were not significant (p = 0.27).
Figure 4. (Top) Pupil responses to blue and red light stimuli for 8 patients with bilateral AION and 
29 control subjects. A curve is fitted through the median pupil contraction amplitude obtained at each 
stimulus intensity for 3 groups of eyes: the worse of two affected eyes of AION patients, the better eyes of 
AION patients and control eyes. (Bottom) Scatterplot of the logI50 for both affected eyes of 8 patients with 
bilateral AION and 29 control eyes. The horizontal bar represents the median value.
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Discussion
Our patients with bilateral AION were generally younger that those with unilateral AION. This is con-
sistent with other studies in which patients with drusen-associated AION are typically younger than 
patients with garden variety NAION31,33. All AION eyes demonstrated loss of visual field and reduction 
of the peripapillary RNFL compared to control eyes, and there were no significant differences in the 
visual function or RNFL between non-arteritic AION eyes and eyes with drusen-associated AION. The 
permanent visual deficit and optic atrophy are consistent with the pathological evidence of retinal gan-
glion cell apoptosis and death in eyes with AION34.
The clinical examination also revealed an RAPD which correlated with the visual field deficit, sug-
gesting that ipRGCs are also affected by this disorder. However, the nature of AION-induced injury to 
ipRGCs is not known. As indicated by histopathologic studies in animals and humans in other optic neu-
ropathies, ipRGCs may have greater resistance to injury and death compared to other vision-mediating 
retinal ganglion cells13,14,16–19. In this study, we assessed the intrinsic melanopsin photoresponse of 
ipRGCs as a measure of their functional integrity. Compared to controls, eyes with AION were less 
able to keep the pupil contracted following offset of a bright (2.0 log cd/m2) blue light, indicating less 
melanopsin influence on the post-illumination behavior of the pupil. In addition, AION eyes showed 
a significant reduction in the pupil responses to scotopic and photopic light stimuli, indicating that the 
pupil contraction driven largely by rods and cones is also impaired in AION. This latter finding raises the 
question whether trans-synaptic degeneration of outer retinal cells could be the basis for explaining all 
the pupil findings in this study. This is not likely as AION is a primary ischemic injury to the prelaminar 
portion of the optic nerve head. Following acute AION, there is axonal thinning and ganglion cell loss34. 
Animal models of AION indicate that the degenerative changes are limited to the inner retina and outer 
photoreceptors are not involved35,36. In humans, there is no definitive clinical evidence of outer retinal 
dysfunction.
Additionally, we have previously shown that the post-illumination pupil response is actually enhanced, 
and not diminished, in patients with primary outer photoreceptor degenerative disorders37. This is pre-
sumably from a pathologic alteration in ipRGC signal integration in which melanopsin input becomes 
increasingly dominant as rods and cones degenerate. Thus we believe the combination of visual deficit, 
optic atrophy, diminished pupil contraction and impaired post-illumination response in eyes with AION 
is best explained by non-selective ganglion cell death in this disorder.
Our finding of impaired post-illumination contraction following monocular bright blue light stim-
ulation in eyes with AION is at odds with previous studies which found no difference in this pupil 
response32,37,38. Small sample size and methodologic variety can probably explain this discrepancy. Each 
study used a different stimulus light under different states of retinal light adaptation to activate mel-
anopsin and each selected a different aspect of the post-stimulus pupillary dynamics as the measure 
Figure 5. Left: Pupillometric recording of the pupil response (median) to a blue light stimulus (2.3 log cd/
m2) presented binocularly to 8 patients with bilateral AION and 29 age-matched control subjects. The 
average of the pupil response of both eyes was used. Note that the pupil tends to stay contracted and  
re-dilation is very slow. The PSPS (pupil size at the 6th second after light termination) is shown by the 
dotted line. Right: Box plot of the average binocular PSPS for the two groups. The center bar is the median 
value, the box limits represent the 25th and 75th percentiles and the bar limits are the 5th and 95th 
percentiles. The difference in PSPS between patients with bilateral AION and controls is not statistically 
significant (p > 0.05).
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of melanopsin activity. Our current testing protocol is an update from previous versions of chromatic 
pupillometry that we have used and has been optimized for preferential activation of one photoreceptive 
system32,39. Protocols using the late phase of the post-stimulus response are prone to excessive variability 
as supranuclear influences on pupillary re-dilation are known to increase with increasing time after light 
termination40.
In this study, patients with bilateral AION had visual dysfunction and loss of RNFL that was simi-
lar between the two affected eyes. When tested independently, each eye also demonstrated diminished 
pupil responses to all light stimuli. When the melanopsin-weighted light stimuli were presented to both 
eyes simultaneously, these patients with bilateral AION showed no difference in the post-stimulus pupil 
response compared to that of patients with unilateral AION and of controls. Reasons for the preservation 
of summated intrinsic activity of ipRGCs to binocular but not monocular stimulation are not known and 
herein are purely speculative. One possibility is binocular summation. Visual tasks based on binocular 
viewing are superior to monocular vision of either eye alone. The model for binocular summation is 
complex, occurs in multiple stages that include the retina, thalamus and cortex, and involves mecha-
nisms of gain control and reciprocal inhibition41,42. Like conventional retinal ganglion cells, ipRGCs 
are integrated into the retinal circuitry, so it may be that this phenomenon also applies to non-visual, 
light-mediated functions such as the pupil response. A related notion is a central threshold of activity. 
Due to hemi-decussation of axons at the optic chiasm, the ipRGC signals from one eye synapse at the 
ipsilateral and the contralateral olivary pretectal nucleus43. The pretectal olivary nucleus is the central 
integrator of all afferent pupillary input and it signals pupillomotor output to the Edinger-Westphal 
nuclei. Binocular pupillary input, even from two damaged optic nerves, may be sufficient to reach a 
threshold level of activity at the olivary pretectal nuclei for sustaining pupillary contraction after stimulus 
offset. Further studies are needed to understand the effects of melanopsin-mediated light signaling from 
one eye compared to two eyes.
Finally, we noted with interest that sleep quality and sleep timing in our patients with bilateral optic 
nerve damage were not different compared to the 29 subjects in the control group. All were morning or 
intermediate types. All except 2 patients and 4 control subjects self-rated their sleep quality as good. The 
unilateral group was classified as a “definitely” morning type, but this qualification might be an effect of 
their older age. It is known that people tend to become more morning type with increasing age after 50 
years44. We are cautious in drawing any conclusions from the sleep questionnaires as those used in this 
study may not be valid for detecting the kinds of sleep disorder associated with loss of ipRGC signaling 
of the hypothalamus. Also, if changes in sleep behavior had occurred at the onset of AION, it is possible 
that adaptation over time has rendered them subjectively unperceived at the present time.
In conclusion, AION results in functional damage to ipRGCs. In affected eyes, the pupil response medi-
ated by either primarily synaptic or primarily intrinsic activation of ipRGCs was reduced. Unexpectedly, 
we found that the summated intrinsic response of ipRGCs was preserved if binocular light exposure was 
given. This was true for patients with unilateral and bilateral AION. Further studies with more rigorous 
methodologies on a wider range of optic nerve damage are needed to better define the impairment of 
ipRGC activity in patients with optic nerve disorders and to better understand how such impairment 
might affect other melanopsin-influenced physiologic functions such as sleep.
Methods
Subjects. All participating subjects gave written informed consent for study participation. The study 
was conducted at the Hôpital Ophtalmique Jules Gonin, Lausanne, Switzerland and conformed to the 
tenets of the Declaration of Helsinki. The study (protocol number 101-09) was reviewed and approved by 
the Commission d’Ethique de la Recherche sur l’être humain which is the local institutional committee 
for ethical research using human subjects for the canton of Vaud in Switzerland. Patients who had been 
diagnosed with AION and followed for at least 2 years in the neuro-ophthalmology unit of the Hôpital 
Ophtalmique Jules Gonin were identified from chart records. Patients with systemic inflammatory dis-
ease known to cause optic neuropathy such as giant cell arteritis, systemic cancer, diabetes mellitus, 
obstructive sleep apnea, major depression, retinal disorder and glaucoma were excluded. In addition, the 
use of somnolent medication such as anti-depressives, anti-histaminics or anxiolytics and recent travel 
across two time zones in the preceding 3 months were exclusionary criteria because these factors influ-
ence the natural sleep habit. Because of the stringent exclusionary criteria, we identified only 50 eligible 
patients from a review of 200 charts classified as “AION”. Eighteen patients with chronic stable visual loss 
for the past 12 months were recruited to participate in the study (Table 1). Twenty nine healthy adults 
without past or present ocular disease participated voluntarily as controls for the study. The same exclu-
sionary criteria applied to the controls. None of the patients or controls was using a topical or systemic 
medication which could adversely influence efferent pupil movements.
All participating subjects underwent ophthalmologic testing (C.T.) which included refraction for 
best-corrected acuity, Ishihara color vision test, threshold automated perimetry (Octopus 101, program 
G1 dynamic, Interzeag, Bern-Köniz, Switzerland), alternating light test with neutral density filters to look 
for a relative afferent pupillary defect (RAPD) and non-dilated funduscopy. Optical coherence tomogra-
phy (OCT; Stratus 3000, Carl Zeiss, Meditec, Inc., Dublin, CA) was used to examine the macular struc-
ture and to quantify the peripapillary retinal nerve fiber layer (RNFL). Control subjects were required to 
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have an acuity of 1.0 or better, normal color vision and normal perimetry with no RAPD and no macular 
lesion identified by funduscopy or OCT.
All subjects completed two sleep questionnaires and pupil testing as described in the following sec-
tions.
Sleep questionnaires. The Horne & Ostberg Morningness-Eveningness questionnaire (HO) and the 
Pittsburgh Sleep Quality Index (PSQI) were used to assess sleep quality and habits. The HO question-
naire consists of 19 multiple-choice items referring to habitual rising and bed times, preferred times of 
mental and physical performance, and subjective alertness after rising and before going to bed27. The 
total numeric score ranges from 16 to 86 with higher scores indicating a greater preference for morning 
activities and earlier bedtime. Subjects are thus classified by their HO score: a score of 70–86 is ‘definitely 
morning type’, 59–69 is ‘moderately morning type’, 42–58 is ‘intermediate type’, 31–41 is ‘moderately 
evening type’ and 16–30 is ‘definitely evening type’28.
The PSQI provides a standardized quantitative measure of sleep quality29. It consists of 19 self-rated 
questions which are combined to assess seven components related to sleep latency, sleep duration, sub-
jective sleep quality, sleep disturbances, habitual sleep efficiency, daytime dysfunction and use of sleep 
medications. Each component is rated from 0 (no difficulty) to 3 (severe difficulty). The global PSQI 
score ranges from 0 to 21 and a score > 5 indicates poor sleep quality.
Pupillometry. A ColorDome Ganzfeld bowl (Diagnosys, Lowell, Massachusetts) was used to present 
computer-controlled, wide-angle light stimuli of a specified duration at two predetermined spectral band-
widths, 635 ± 20 nm (red light) and 464 ± 26 nm (blue light). A chinrest set at the bowl opening gives a 
viewing angle of 45 degrees horizontal radius. The pupil diameter was monitored at 60 Hz and contin-
uously recorded using a portable dual channel pupillometer (Arrington Research, Scottsdale, Arizona).
Computerized chromatic pupillography was performed under conditions of dark- and light-adaptation. 
Based on previous investigations using this apparatus20,39,45,46, we defined 4 testing protocols which 
selected for afferent pupillomotor input derived primarily from synaptic signals from outer retinal photo-
receptors (rods and cones) or from its intrinsic melanopsin activity of ipRGCs . For the first three testing 
protocols, each eye was tested monocularly. The eye receiving light stimulation was also the recorded eye 
while the non-tested eye was kept under patch occlusion. By convention, the right eye was always tested 
first. For the fourth testing protocol, light stimulation was presented to both eyes simultaneously. The 
following paragraph summarizes the stimulus conditions of the 4 testing protocols (Fig. 1).
Test 1 (rod-weighted protocol): The tested eye was dark-adapted (0 cd/m2) for 10 minutes. The pupil 
of the dark-adapted eye was recorded for 10 seconds in total darkness and then in response to a series of 
dim, 1-second blue light stimuli starting at − 4.0 log cd/m2 and increasing by 0.5 log-unit steps to –1.0 log 
cd/m2 (0 log cd/m2 = 1 cd/m2). The dark interval between light stimuli had been previously determined 
to allow the pupil to return to baseline size before the next light stimulation. Test 2 (cone-weighted pro-
tocol): The tested eye was light-adapted (90 cd/m2) for 5 minutes and the pupil was similarly recorded, 
as in the rod protocol, to 1-second red light stimuli ranging from 1.0 to 2.5 log cd/m2 (in 0.5 log steps). 
Test 3 (monocular melanopsin-weighted protocol) followed the cone-weighted protocol and thus was 
performed under photopic conditions. The light stimulation consisted of three 1-second blue lights at 
intensities of 1.0, 1.5 and 2.0 log cd/m2. After the last blue light stimulus, the pupil was recorded con-
tinuously in darkness for 35 seconds in order to observe the dynamics of the post-stimulus pupillary 
response39. Test 4 (binocular melanopsin-weighted protocol) was also performed under photopic condi-
tions. A bright 1-second red light and then a bright 1-second blue light were presented. The red and blue 
lights were equiluminant for photopic sensitivity at 2.3 log cd/m2, according to the manufacturer of the 
Ganzfield apparatus (=14.9 log quanta for blue light and 15.1 log quanta for red light). The pupils were 
recorded in darkness for 30 seconds after the red light and for 60 seconds after the blue light.
Analysis of pupil tracings. The video signal from the pupillometer was relayed to a processing board 
which recorded the maximal pupil diameter in real time into a text file. Analysis of the pupil data was 
performed in a spreadsheet. A customized filter was applied to remove gross artifacts from blinking and 
eye movements (Microsoft Excel 2010, Visual Basic for Applications). Baseline pupil size was defined 
from the average size during 1 second before onset of each light stimulus. Actual pupil size at any given 
time point was divided by baseline pupil size to convert all values to relative pupil size (RPS). For the 
rod-weighted and cone-weighted protocols, the immediate pupil contraction to light stimulation was 
determined as a maximal percentage change from baseline by the equation: (1 - minimum RPS) X 100. 
The calculated pupil contraction was plotted as a function of stimulus light intensity for each eye of each 
subject using nonlinear curve fit analysis in order to generate a stimulus response curve which charac-
terized the retinal sensitivity to light over the intensity range of each protocol45. As the response curves 
appeared to reach an asymptote (maximal response), the light intensity at which a 50% pupil response 
occurred (logI50) was determined.
When melanopsin contribution to the pupil response is dominant, the pupil tends to stay small and 
contracted, instead of promptly re-dilating after the light stimulus has been turned off2,4,11. The degree 
of post-illumination pupillary contraction varies with the light stimulus characteristics. The outcome 
parameter we chose to estimate the post-stimulus contraction was the pupil size at the 6th second after 
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light termination, or post-stimulus pupil size (PSPS). The post-stimulus pupil size was determined as the 
mean RPS between 5.5 s and 6.5 s after light termination. The PSPS as a clinical measure of melanopsin 
activity has been described and used in previous investigations39,46. In the binocular melanopsin-weighted 
protocol, a single blue light (2.3 log cd/m2 = 14.9 log quanta) was used as the melanopsin stimulus and 
an equiluminant red light stimulus was used as a reference stimulus . Afferent pupillary input derived 
from red light has little, if any, melanopsin contribution under conditions of this study39. Thus, for the 
binocular protocol, we calculated both the absolute blue light PSPS as well as the difference in the PSPS 
between red and blue light. In this way, potential confounding central effects on the post-stimulus pupil 
response could be detected and controlled.
Statistical Analysis. Statistical analyses were carried out using the SPSS 21 software. Descriptive 
statistics were performed to characterize the distribution of age, acuity, color vision, MD, RNFL, RAPD, 
logI50 for rod-weighted and cone-weighted protocols, PSPS of melanopsin-weighted protocols and sleep 
questionnaire scores on three groups: controls, patients with unilateral AION and patients with bilateral 
AION. The data are presented as median values and the ranges. Due to the small number of subjects 
in each group, a non-normal distribution was assumed and non-parametric tests were applied for the 
comparisons. The Mann-Whitney U test was used for two independent samples, and for more than two 
independent samples, the Kruskal-Wallis test was used. The Wilcoxon signed rank test was used for 
paired samples comparisons. To look for a correlation between variables, a Spearman’s rank correlation 
coefficient was estimated. In all statistical analyses, two-sided tests were used and the results were con-
sidered statistically significant if p was less than 0.05.
References
1. Provencio, I. et al. A novel human opsin in the inner retina. J. Neurosci. 20, 600–605 (2000).
2. Berson, D. M., Dunn, F. A. & Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295, 
1070–1073 (2002).
3. Bailes, H. J. & Lucas, R. J. Melanopsin and inner retinal photoreception. Cell. Mol. Life. Sci. 67, 99–111 (2010).
4. Dacey, D. M. et al. Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. 
Nature 433, 749–754 (2005).
5. Hattar, S., Liao, H. W., Takao, M., Berson, D. M. & Yau, K. W. Melanopsin-containing retinal ganglion cells: architecture, 
projections, and intrinsic photosensitivity. Science 295, 1065–1070 (2002).
6. Gamlin, P. D. et al. Human and macaque pupil responses driven by melanopsin-containing retinal ganglion cells. Vision Res. 47, 
946–954 (2007).
7. Wong, K. Y., Dunn, F. A., Graham, D. M. & Berson, D. M. Synaptic influences on rat ganglion-cell photoreceptors. J. Physiol. 
582, 279–296 (2007).
8. Guler, A. D. et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature 453, 
102–105 (2008).
9. Lucas, R. J. et al. Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice. Science 299, 245–247, 
doi:10.1126/science.1077293 (2003).
10. Tsujimura, S. & Tokuda, Y. Delayed response of human melanopsin retinal ganglion cells on the pupillary light reflex. Ophthalmic 
Physiol. Opt. 31, 469–479 (2011).
11. McDougal, D. H. & Gamlin, P. D. The influence of intrinsically-photosensitive retinal ganglion cells on the spectral sensitivity 
and response dynamics of the human pupillary light reflex. Vision Res. 50, 72–87 (2010).
12. Kankipati, L., Girkin, C. A. & Gamlin, P. D. Post-illumination pupil response in subjects without ocular disease. Invest. 
Ophthalmol. Vis. Sci. 51, 2764–2769 (2010).
13. Li, R. S. et al. Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. 
Invest. Ophthalmol. Vis. Sci. 47, 2951–2958 (2006).
14. Li, S. Y. et al. Enhanced survival of melanopsin-expressing retinal ganglion cells after injury is associated with the PI3 K/Akt 
pathway. Cell. Mol. Neurobiol. 28, 1095–1107 (2008).
15. Robinson, G. A. & Madison, R. D. Axotomized mouse retinal ganglion cells containing melanopsin show enhanced survival, but 
not enhanced axon regrowth into a peripheral nerve graft. Vision Res. 44, 2667–2674 (2004).
16. DeParis, S., Caprara, C. & Grimm, C. Intrinsically photosensitive retinal ganglion cells are resistant to N-methyl-D-aspartic acid 
excitotoxicity. Mol. Vis. 18, 2814–2827 (2012).
17. Sadun, A. A., Win, P. H., Ross-Cisneros, F. N., Walker, S. O. & Carelli, V. Leber’s hereditary optic neuropathy differentially affects 
smaller axons in the optic nerve. Trans. Am. Ophthalmol. Soc. 98, 223–232; discussion 232–225 (2000).
18. Perganta, G. et al. Non-image-forming light driven functions are preserved in a mouse model of autosomal dominant optic 
atrophy. PLoS One 8, e56350 (2013).
19. La Morgia, C. et al. Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. 
Brain 133, 2426–2438 (2010).
20. Kawasaki, A., Collomb, S., Leon, L. & Munch, M. Pupil responses derived from outer and inner retinal photoreception are 
normal in patients with hereditary optic neuropathy. Exp. Eye. Res. 120, 161–166 (2014).
21. Moura, A. L. et al. The pupil light reflex in Leber’s hereditary optic neuropathy: evidence for preservation of melanopsin-
expressing retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 54 (2013).
22. Kankipati, L., Girkin, C. A. & Gamlin, P. D. The post-illumination pupil response is reduced in glaucoma patients. Invest. 
Ophthalmol. Vis. Sci. 52, 2287–2292 (2011).
23. Feigl, B., Mattes, D., Thomas, R. & Zele, A. J. Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma. 
Invest. Ophthalmol. Vis. Sci. 52, 4362–4367 (2011).
24. Perez-Rico, C., de la Villa, P., Arribas-Gomez, I. & Blanco, R. Evaluation of functional integrity of the retinohypothalamic tract 
in advanced glaucoma using multifocal electroretinography and light-induced melatonin suppression. Exp. Eye. Res. 91, 578–583 
(2010).
25. Lanzani, M. F. et al. Alterations of locomotor activity rhythm and sleep parameters in patients with advanced glaucoma. 
Chronobiol. Int. 29, 911–919 (2012).
26. Zhang, C., Guo, Y., Slater, B. J., Miller, N. R. & Bernstein, S. L. Axonal degeneration, regeneration and ganglion cell death in a 
rodent model of anterior ischemic optic neuropathy (rAION). Exp. Eye Res. 91, 286–292 (2010).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:10780 | DOi: 10.1038/srep10780
27. Horne, J. A. & Ostberg, O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. 
Int. J. Chronobiol. 4, 97–110 (1976).
28. Taillard, J., Philip, P., Chastang, J. F. & Bioulac, B. Validation of Horne and Ostberg morningness-eveningness questionnaire in 
a middle-aged population of French workers. J. Biol. Rhythms 19, 76–86 (2004).
29. Buysse, D. J., Reynolds, C. F., 3rd, Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh Sleep Quality Index: a new 
instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213 (1989).
30. Fisher, S. P., Foster, R. G. & Peirson, S. N. The circadian control of sleep. Handb. Exp. Pharmacol., 157–183 (2013).
31. Purvin, V., King, R., Kawasaki, A. & Yee, R. Anterior ischemic optic neuropathy in eyes with optic disc drusen. Arch. Ophthalmol. 
122, 48–53 (2004).
32. Kardon, R. et al. Chromatic pupil responses: preferential activation of the melanopsin-mediated versus outer photoreceptor-
mediated pupil light reflex. Ophthalmology 116, 1564–1573 (2009).
33. Nanji, A. A., Klein, K. S., Pelak, V. S. & Repka, M. X. Nonarteritic anterior ischemic optic neuropathy in a child with optic disk 
drusen. J. A.A.P.O.S. 16, 207–209 (2012).
34. Levin, L. A. & Louhab, A. Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy. Arch. Ophthalmol. 114, 
488–491 (1996).
35. Bernstein, S. L., Guo, Y., Kelman, S. E., Flower, R. W. & Johnson, M. A. Functional and cellular responses in a novel rodent model 
of anterior ischemic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 44, 4153–4162 (2003).
36. Chuman, H. et al. Rodent model of nonarteritic ischemic optic neuropathy and its electrophysiological evaluation. Jpn. J. 
Ophthalmol. 56, 518–527 (2012).
37. Leon, L., Crippa, S. V., Borruat, F. X. & Kawasaki, A. Differential effect of long versus short wavelength light exposure on 
pupillary re-dilation in patients with outer retinal disease. Clin Experiment. Ophthalmol. 40, e16–24 (2012).
38. Herbst, K. et al. Unilateral anterior ischemic optic neuropathy: chromatic pupillometry in affected, fellow non-affected and 
healthy control eyes. Front. Neurol. 4, 52 (2013).
39. Park, J. C. et al. Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response. 
Invest. Ophthalmol. Vis. Sci. 52, 6624–6635 (2011).
40. Loewenfeld, I. E. & Lowenstein, O. The pupil : anatomy, physiology, and clinical applications. 1st edn, (Iowa State University Press; Wayne 
State University Press, 1993).
41. Ding, J. & Sperling, G. A gain-control theory of binocular combination. Proc. Natl. Acad. Sci. U.S.A. 103, 1141–1146 (2006).
42. Moradi, F. & Heeger, D. J. Inter-ocular contrast normalization in human visual cortex. J. Vis. 9, 13,  11–22 (2009).
43. Kardon, R., Kawasaki, A. & Miller, N. R. Origin of the relative afferent pupillary defect in optic tract lesions. Ophthalmology 113, 
1345–1353 (2006).
44. Bliwise, D. L., Ansari, F. P., Straight, L. B. & Parker, K. P. Age changes in timing and 24-hour distribution of self-reported sleep. 
Am. J. Geriatr. Psychiatry 13, 1077–1082 (2005).
45. Kawasaki, A., Crippa, S. V., Kardon, R., Leon, L. & Hamel, C. Characterization of pupil responses to blue and red light stimuli 
in autosomal dominant retinitis pigmentosa due to NR2E3 mutation. Invest. Ophthalmol. Vis. Sci. 53, 5562–5569 (2012).
46. Munch, M., Leon, L., Crippa, S. V. & Kawasaki, A. Circadian and wake-dependent effects on the pupil light reflex in response 
to narrow-bandwidth light pulses. Invest. Ophthalmol. Vis. Sci. 53, 4546–4555 (2012).
Acknowledgements
We wish to thank Professor F.-X. Borruat ( Neuro-ophthalmology unit) and Mr. M. Curchod (department 
of photography) for their assistance in patient recruitment.
Author Contributions
C.T. collected the data. S.C. prepared the figures. A.K. wrote the main text. All authors contributed in the 
data analysis and the writing of the text. All authors reviewed the manuscript and approved all revisions.
Additional Information
Competing financial interests: Dr. Kawasaki was supported in part by a grant from the Foundation 
for Research in Ophthalmology and Loterie Romande Switzerland. She has received book royalties 
from Cambridge University Press. Dr. Tsika and Mr. Crippa declare no potential conflict of interest.
How to cite this article: Tsika, C. et al. Differential monocular vs. binocular pupil responses from 
melanopsin-based photoreception in patients with anterior ischemic optic neuropathy. Sci. Rep. 5, 
10780; doi: 10.1038/srep10780 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
